Episteme Prognostics, Inc. announced it raised $80,000 in an initial filing from an offering of $3 Million

Jan 03, 2022•almost 4 years ago

Amount Raised

$80,000

Round Type

pre-seed

BrooklynBiotechnology

Company Information

Company

Episteme Prognostics

Location

760 Parkside Avenue

Brooklyn, New York, United States

About

Episteme Prognostics is a precision medicine company that develops therapeutic biomarkers for pancreatic cancer. It predicts chemotherapy response and assesses the benefit of epigenetic therapy to pancreatic cancer patients.

Related People

1 contact

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Episteme Prognostics, Inc. announced it raised $80,000 in an initial filing from an offering of $3 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information